Deltona, FL 的 非小細胞肺癌 臨床試驗
15 項針對 非小細胞肺癌 的研究正在 Deltona（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
招募中1/2 期
- Mid Florida Hematology And Oncology Center /ID# 273777, Orange City · 距離 4 英里
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
招募中3 期
- Mid Florida Hematology and Oncology Center ( Site 0018), Orange City · 距離 4 英里
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
招募中3 期
- Alpha Clinical Research Centers LLC, Orange City · 距離 4 英里
- Florida Cancer Specialists, Orange City · 距離 4 英里
- Mid Florida Hematology and Oncology Center, Orange City · 距離 4 英里
- 還有 1 項
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
招募中3 期
- Mid Florida Hematology and Oncology Center, Orange City · 距離 4 英里
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
招募中1/2 期
- Mid Florida Hematology and Oncology Center, Orange City · 距離 4 英里
Pan-tumor MRD Study
招募中觀察性研究
- Mid Florida Cancer Centers, Orange City · 距離 4 英里
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
招募中3 期
- Research Site, Orange City · 距離 4 英里
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
招募中3 期
- Mid Florida Hematology and Oncology Center, Orange City · 距離 4 英里
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
招募中2/3 期
- Mid Florida Cancer Centers, Orange City · 距離 4 英里
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
招募中3 期
- Mid Florida Hematology and Oncology Center, Orange City · 距離 4 英里
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
招募中2/3 期
- Local Institution - 007-926-B, Daytona Beach · 距離 26 英里
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
招募中3 期
- Mid-Florida Hematology & Oncology Centers, P.A., Orange City · 距離 4 英里
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
招募中3 期
- Research Site, Orange City · 距離 4 英里
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
招募中1/2 期
- Mid Florida Hematology and Oncology Center, Orange City · 距離 4 英里
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
招募中2 期
- Mid Florida Hematology and Oncology Center, Orange City · 距離 4 英里
其他城市的 非小細胞肺癌 試驗
- Houston, TX145 項研究
- New York City, NY121 項研究
- Arlington, VA104 項研究
- Nashville, TN97 項研究
- Boston, MA90 項研究
- Los Angeles, CA87 項研究
- St. Louis, MO73 項研究
- Chicago, IL61 項研究
- Baltimore, MD60 項研究
- San Antonio, TX59 項研究
- Columbus, OH57 項研究
- Washington, DC55 項研究
Deltona 的其他研究
- 肥胖症11 項研究
- 阿茲海默症10 項研究
- 第二型糖尿病10 項研究
- 過重9 項研究
- 乳癌8 項研究
- 肺癌8 項研究
- 癌症（所有類型）7 項研究
- 轉移性癌症5 項研究
- 慢性阻塞性肺病5 項研究
- 高血壓5 項研究
- 黑色素瘤5 項研究
- 膝關節骨關節炎5 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。